Blood DNA biomarkers track progression during prostate cancer radioligand therapy
A prospective observational study linked circulating tumor DNA fraction and copy-number burden with progression and survival in 78 patients receiving ...
A prospective observational study linked circulating tumor DNA fraction and copy-number burden with progression and survival in 78 patients receiving ...
A real-world analysis of 218 patients with metachronous metastatic nasopharyngeal carcinoma proposed a prognostic classification combining metastatic-lesion count with disease-free ...
A retrospective single-center cohort found that acute pancreatitis during immune checkpoint inhibitor therapy was associated with treatment disruption and substantially ...
A retrospective study of 74 resected esophagogastric junction adenocarcinomas found longer overall survival in HER2-low tumors, but HER2-low status was ...
A Johns Hopkins retrospective cohort study found 96% overall survival among 23 children and young adults with severe aplastic anemia ...
A retrospective cohort of 331 initially diagnosed patients with HCC and Vp3/4 portal vein tumor thrombosis found a 61.3% objective ...
A retrospective Hawaiian study of 84 surgically treated hepatocellular carcinoma patients found that carrying at least one copy of the ...
A tissue microarray study of 347 clear cell renal cell carcinomas finds that p16 expression in intratumoral blood vessels, rather ...
A retrospective study of 102 adults with grade 4 gliomas in the Democratic Republic of the Congo linked gross total ...
The phase III TAISHAN-302 trial found that the anti-B7-H3 antibody-drug conjugate Tam-Peli reduced the risk of death by 54 percent ...
A meta-analysis of six randomized trials found that adding PD-1/PD-L1 inhibitors to chemotherapy was associated with longer progression-free and overall ...
A prespecified interim analysis of the phase 3 HARMONi-2 trial shows ivonescimab achieved median overall survival of 30.8 months versus ...
A retrospective cohort of 163 patients treated at one Rwandan cancer center reported estimated median overall survival of 3.68 years ...
A retrospective study of 430 surgically treated patients links elevated inflammation, thyroid-related blood markers and selected immune-cell measures with survival ...
A retrospective study of 47 patients found that high folate receptor alpha expression was independently associated with shorter progression-free survival ...
A two-center retrospective cohort study of 823 surgically resected pulmonary neuroendocrine carcinoma patients found that a Transformer-based AI model achieved ...
A single-center cohort study linked checkpoint inhibitor-containing therapy with longer unadjusted progression-free survival in advanced SMARCA4-deficient thoracic tumors, but adjusted ...
A meta-analysis of fourteen retrospective cohort studies associates TACE-HAIC combined with targeted therapy and immune checkpoint inhibitors with improved survival ...
A retrospective cohort study of 194 patients with esophageal squamous cell carcinoma found that postoperative pathological lymph node stage, rather ...
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.